Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti-cancer Drug Development
Cyclica, the partner of choice for data-driven drug discovery, and IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics with synthetic lethality approach, announce today that they have entered to a collaboration agreement on IMPACT Therapeutics differentiated targeted anti-cancer drug development.